Scintigraphy with 99mTc-MIBI of the axillary lymph node invasion of the breast cancer;Gammagrafía con 99mTc-MIBI en el diagnóstico de la invasión ganglionar axilar del cáncer de mama

Revista Espanola de Medicina Nuclear

Volumn 19, Issue 6, 2000, Pages 416-422

  Mulero Aniorte, F ^a,b   Nicolas F ^a   Castellon M I ^a   Claver, M A ^a   Abad, L ^a   Nuno De La Rosa J A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b NONE   (Spain)

Author keywords

Axillary lymph nodes; Breast cancer; Breast scintigraphy

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG UPTAKE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; RADIATION DOSE; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; AXILLA; BREAST TUMOR; CANCER INVASION; FEMALE; LYMPH NODE; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 0034292956     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/s0212-6982(00)71903-3     Document Type: Article

References (28)

1. Bombardieri E, Crippa F, Maffioli L, Draisma A, Chiti A, Agresti R, et al. Nuclear medicina approaches for detection of axillary lymph node metastases. Q J Nucl Med 1998;42:54-65.
2. Feldman S, Krag D, McNally R, Moor B, Weaver D, Klein P. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg 1999;188:248-54.
3. Barnwell J, Arredondo M, Kollmorgen D, Gibbs J, Lamonica D, Carson W, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998;5:126-30.
4. Jaderborg J, Harrison P, Kiser J, Maynard S. The feasibility and accuracy of the sentinel lymph node biopsy for breast carcinoma. Am Surg 1999;65:699-703.
5. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368-73.
6. Alazraki N, Eshima D, Herda S, Murray D, Vansant J, Taylor A. Lymphoscintigraphy, the sentinel node concept, and intraoperative gamma probe in Melanoma, Breast cancer, and other potential cancers. Sem Nucl Med 1997;27:55-67.
7. Crippa F, Agresti R, Seregni E, Greco M, Pascali C, Bogni A, et al. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer. 1998;39:4-8.
8. Yutani K, Tatsumi M, Shiba E, Kusuoka H, Nishimura T. Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis. 1999;40:1003-8.
9. Hoh C, Schiepers C. 18-FDG imaging in breast cancer. Semin Nucl Med 1999;23:49-56.
10. Hatahaway P, Mankoff D, Maravilla K, Austin M, Ellis G, Gralow J, et al. Value of combined FDG PET and MR imaging in the evaluation of uspected recurrente local-regional breast cancer: preliminary experience. Radiology 1999;210:807-14.
11. Holland R, Veling S, Mravunac M. Histologic multifocality of Tis, T1-2 breast carcinomas. Cancer 1985;56:979-83.
12. Harris J, Hellman S. Natural history of breast cancer. En: Diseases of the breast, edited by Harris J, Lippman M, Morrow M. Lippincott-Raven Publishers, Philadelphia; 1996. p. 375-91.
13. Quiet C, Ferguson D, Weichslbaum R, Hellman S. The natural history of node negative breast cancer: predictors of outcome with 40 years follow-up. Proc Am Soc Clin Oncol 1993;12:73-80.
14. Quiet C, Ferguson D, Weichslbaum R. History of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes. J Clin Oncol 1996;12:3105-11.
15. 99mTc-MIBI mammoscintigraphy of breast masses: early and delayed imaging. Nucl Med Commun 1995;16:150-6.
16. 99m-sestamibi breast scintigraphy, ultrasound and conventional mammography. Eur J Nucl Med 1996;23:498-503.
17. Khalkhali I, Cutrone J, Diggles L, Iraniha S, Klein S. The role of Nuclear Medicine Imaging for the Evaluation of patients with Breast abnormalities. En: Nuclear Medicine Annual 1996. Editado por Freeman L. Lippincott-Raven Publishers, Philadelphia; 1996. p. 113-41.
18. 99mTc-sestamibi breast imaging in breast cancer detection (abstract). J Nucl Med 1996;37:74.
19. Bombardieri E, Crippa F, Maffioli G, et al. Nuclear Medicine techniques for the study of breast cancer. Eur J Nucl Med 1997;24:809-24.
20. 99mTc-Methoxyisobutitylisonitrile in imaging breast cancer. Sem Nucl Med 1997;2740-54.
21. 99mTc-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758-65.
22. 99mTc-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 1994;15:604-12.
23. Tolmos J, Khalkhali I, Vargas H, Stuntz M, Cutrone J, Mishkin F, et al. Detection of axillary lymph node metastasis of breast carcinoma with technetium-99m sestamibi scintimammography. Am Coll Surgeon 1997;63:850-3.
24. 99mTc-sestamibi and Tl-201. J Nucl Med 1993;34:1949-52.
25. Palmedo H, Shomburg A, Grünwald F, Mallmann P, Boldit I, Biersack H. Scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;37:626-30.
26. 99mTc-sestamibi scintimammography in patients with suspicious breast lesions: comparison of SPET and planar images in the detection of primary tumours and axillary lymph node involvement. Nucl Med Commun 1997;18:839-45.
27. 99mTc-sestamibi in the diagnosis of breast carcinoma. Acta Radiol 1998;40:176-80.
28. 99mTc-technetium methoxyisobutylisonitrile scintimammography in the detection of breast tumours. Eur J Nucl Med 1997;24:1138-45.